G3BP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.298600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.589800E-01
Normal-vs-Stage2
8.865000E-01
Normal-vs-Stage3
1.235820E-01
Normal-vs-Stage4
3.225200E-01
Stage1-vs-Stage2
8.052400E-01
Stage1-vs-Stage3
7.151600E-02
Stage1-vs-Stage4
2.826800E-01
Stage2-vs-Stage3
9.630200E-02
Stage2-vs-Stage4
7.844300E-02
Stage3-vs-Stage4
7.175900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.506800E-01
Normal-vs-AfricanAmerican
7.324800E-01
Normal-vs-Asian
9.083200E-01
Caucasian-vs-AfricanAmerican
5.706200E-01
Caucasian-vs-Asian
7.031200E-01
AfricanAmerican-vs-Asian
5.698600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.019800E-01
Normal-vs-Female
9.558400E-01
Male-vs-Female
7.719200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.430600E-01
Normal-vs-Age(41-60Yrs)
4.951400E-01
Normal-vs-Age(61-80Yrs)
8.641800E-01
Normal-vs-Age(81-100Yrs)
7.296400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.000600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.395800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.450400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.341900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.367500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.406600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.770600E-01
Normal-vs-Daily Drinker
7.782200E-01
Normal-vs-Weekly Drinker
6.382000E-01
Normal-vs-Occasional Drinker
7.027200E-01
Normal-vs-Social Drinker
9.697400E-01
Non Drinker-vs-Daily Drinker
7.539400E-01
Non Drinker-vs-Weekly Drinker
6.343200E-01
Non Drinker-vs-Occasional Drinker
2.491600E-01
Non Drinker-vs-Social Drinker
7.207600E-01
Daily Drinker-vs-Weekly Drinker
8.730800E-01
Daily Drinker-vs-Occasional Drinker
2.080000E-01
Daily Drinker-vs-Social Drinker
5.651800E-01
Weekly Drinker-vs-Occasional Drinker
1.887970E-01
Weekly Drinker-vs-Social Drinker
4.589000E-01
Occasional Drinker-vs-Social Drinker
5.100600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.729400E-01
Normal-vs-Grade 2
1.166800E-01
Normal-vs-Grade 3
1.173410E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.653900E-02
Grade 1-vs-Grade 3
2.112200E-02
Grade 1-vs-Grade 4
4.729400E-01
Grade 2-vs-Grade 3
4.977200E-01
Grade 2-vs-Grade 4
1.166800E-01
Grade 3-vs-Grade 4
1.173410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.353000E-01
Normal-vs-NonDiabetic
9.884600E-01
Diabetic-vs-NonDiabetic
4.685400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.972800E-01
Normal-vs-NoPancreatitis
9.691200E-01
Pancreatitis-vs-NoPancreatitis
7.976800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.318000E-01
Normal-vs-N1
8.581800E-01
N0-vs-N1
3.667800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.016600E-01
Normal-vs-TP53-NonMutant
9.553800E-01
TP53-Mutant-vs-TP53-NonMutant
1.262280E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
